Metraipolis › archive › dc_08c3b067f2eb

Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten — Europe PMC PMID:42149075

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42149075
DOI
10.1016/j.jaccas.2026.108253
License (as archived)
solo-consultazione
Archived
2026-11-01T13:53:09.361Z
SHA-256 of the archived text
2db16b1e3cac5c3eb057ab96a56fa97e1db9a4f6b71f576245ad263e0e08531b
Stable URL of this page
https://metraipolis.com/documento/dc_08c3b067f2eb

How to cite

Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten — Europe PMC PMID:42149075 — Europe PMC (en), https://europepmc.org/article/MED/42149075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08c3b067f2eb (Metraipolis archive dc_08c3b067f2eb, sha256 2db16b1e3cac5c3eb057ab96a56fa97e1db9a4f6b71f576245ad263e0e08531b)
BibTeX
@misc{dc08c3b067f2eb,
  title = {Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten — Europe PMC PMID:42149075},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42149075},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08c3b067f2eb; sha256 2db16b1e3cac5c3eb057ab96a56fa97e1db9a4f6b71f576245ad263e0e08531b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42149075. Agents can read the archived copy with the MCP tool read_document.